• SENSEX 77,928.15
    273.55 (+0.35%)
  • BANKNIFTY 57,147.50
    -58.40 (--0.10%)
  • Indo-MIM
    757.50 757.50(%)
  • Bajaj Finserv
    1,891.35 1,598.15(%)
  • Bajaj Finance
    1,067.05 1,102.45(%)
  • ICICI Bank
    1,423.00 1,187.55(%)
  • HDFC Bank
    758.00 1,020.35(%)
  • Adani Green
    1,350.10 767.00(%)
  • Reliance Industries
    1,298.00 1,611.20(%)
  • DLF
    652.05 489.30(%)
  • TBO Tek
    1,473.20 1,005.50(%)
  • Eicher Motors
    7,929.00 8,232.80(%)
  • Kalyan Jewellers
    649.00 649.00(%)
  • M & M
    3,325.00 3,840.00(%)
  • TVS Motor Co.
    4,219.00 4,219.00(%)
  • Infosys
    1,187.00 1,727.85(%)
  • Coforge
    1,763.70 1,988.90(%)
  • Jubilant Food.
    433.80 408.50(%)
  • Waaree Energies
    2,563.00 2,402.00(%)
  • Cholaman.Inv.&Fn
    1,758.65 1,299.80(%)
  • Redington
    338.20 338.20(%)
  • SBI
    1,030.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novartis India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 243.0
  • ISIN : INE234A01025
1,575.50 -20 (-1.28%)
  • As on 30 Jul 2026 (EOD)

  • Today’s Low

    1,569.40

  • Today’s High

    1,657.80

  • Open

    1,610.00

  • Perv Close

    1,595.90

  • 52W Low

    950.00

  • 52W High

    1,780.00

Key Indicators

  • P/E(TTM)

    39.72

  • Mar.Cap (₹Cr.)

    3,890.04

  • Div & Yield %

    0.00

  • Book Value(₹)

    331.23

  • Debt-Equity Ratio

    -1.28

  • AGM Date

    30-Jul-2026

  • EPS

    39.60

  • P/E Ratio

    39.72

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,890.04

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.35

  • BV (₹)

    331.20

  • Sales( ₹ in Cr.)

    354.33

  • NP (in Cr.)

    93.18

  • NP Var(%)

    -8.0

  • Div%

    0.0

  • CPS (₹)

    38.50

  • EPS (₹)

    37.70

  • Traded Value (₹ in Lakhs)

    3,883.49

  • 52 Week High

    1,780.00

  • 52 Week Low

    950.00

  • Price BSE

    1573.0

  • Price NSE

    1,576.00

  • Market Capital( in Cr.)

    3,883.49

  • P/C Ratio

    40.80

  • P/E Ratio

    41.70

  • Price Vs.BV

    37.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 390.09 366.84 413.52 486.66 453.73 532.69
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 390.09 366.84 413.52 486.66 453.73 532.69
Other Income 41.96 61.68 58.11 33.19 33.09 36.14
Stock Adjustments -3.75 -9.86 -2.35 9.12 -10.74 -1.83
Total Income 428.30 418.66 469.28 528.97 476.08 567.00
EXPENDITURE :            
Raw Materials 199.07 189.98 199.34 187.26 135.88 180.49
Power and Fuel Cost 0.14 0.18 0.35 0.53 0.53 1.27
Employee Cost 18.72 22.96 35.64 101.89 108.51 113.87
Other Manufacturing Expenses 8.18 5.00 12.58 31.15 33.51 36.19
Selling and Administration Expenses 59.74 65.55 82.78 144.40 128.11 174.87
Miscellaneous Expenses 9.07 8.05 15.40 53.08 9.66 12.14
Employee Benefit Expenses 18.72 22.96 35.64 101.89 108.51 113.87
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 294.92 291.72 346.09 518.31 416.20 518.83
Operating Profit 133.38 126.94 123.19 10.66 59.88 48.17
Interest 0.77 1.49 1.75 4.83 7.68 6.39
Gross Profit 132.61 125.45 121.44 5.83 52.20 41.78
Depreciation 2.19 2.61 6.06 9.65 12.16 13.14
Profit Before Tax 130.42 122.84 115.38 -3.82 40.04 28.64
Current Tax 29.96 37.63 1.68 -0.44 22.62 15.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.02 10.34 0.34 -3.48 3.34
Reported Net Profit 100.90 85.19 103.36 -3.72 20.90 10.08
Extraordinary Items 0.08 1.99 0.17 -44.68 0.03 -0.01
Adjusted Net Profit 100.82 83.20 103.19 40.96 20.87 10.09
Adjustment below Net Profit 0.97 1.21 3.11 8.19 -6.09 -24.81
P & L Balance brought forward 728.84 759.72 677.94 698.16 708.04 747.46
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 61.73 117.28 24.69 24.69 24.69 24.69
P & L Balance carried down 768.98 728.84 759.72 677.94 698.16 708.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 950.00 200.00 200.00 200.00
Dividend Per Share(Rs) 25.00 25.00 47.50 10.00 10.00 10.00
Earnings Per Share-Unit Curr 40.88 34.52 41.88 -1.51 8.47 4.08
Earnings Per Share(Adj)-Unit Curr 40.88 34.52 41.88 -1.51 8.47 4.08
Book Value 318.06 301.79 314.29 280.27 288.16 292.03
Book Value(Adj)-Unit Curr 318.06 301.79 314.29 280.27 288.16 292.03

Shareholding Pattern

  • Promoter Group

    70.68%

  • Public Share Holding

    29.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 17,450,680 70.68 17,450,680 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 17,450,680 70.68 17,450,680 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,604 0.01 1,907 12
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 40,037 0.16 40,037 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 125,456 0.51 125,456 1
Mutual Funds / UTI 170,901 0.69 170,441 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 35,995 0.15 35,995 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 374,993 1.52 373,836 30
2] Non Institution
Bodies Corporate 498,956 2.02 498,916 196
Clearing Members 14,627 0.06 14,627 23
Directors of their Relatives 35 0.00 35 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 263,986 1.07 262,044 884
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 291,635 1.18 291,625 904
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 784,683 3.18 784,683 7
Individuals holding nominal share capital up to Rs. 1 lakh 4,769,708 19.32 4,573,651 34,432
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,036 0.00 1,036 3
Others 175,075 0.71 175,075 1
Sub Total 6,865,124 27.80 6,666,950 36,471
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 24,690,797 100.00 24,491,466 36,502

Company Background

Novartis India LtdPharmaceuticals - Multinational

  • Novartis India Ltd
  • BSE Code : 243.0
  • ISIN : INE234A01025

  • Incorporation Year

    1947

  • Registered Office

    The Inspire BKC Part 601 & 701
    Bandra Kurla Complex Bandra(E), Mumbai,
    Maharashtra-400051

  • Telephone

    91-022-50243000

  • FAX

    91-022-50243010

  • Chairman

    C Snook

  • Managing Director

  • Company Secretary

    Chandni Maru

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Novartis India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novartis India 1,572.85 398.23 356.27 39.72 16.64
Abbott India 27,566.00 7,217.19 6,929.05 37.74 43.78
Astrazeneca Phar 8,090.05 2,304.07 2,275.58 107.85 27.86
P & G Health Ltd 6,502.50 944.52 934.17 33.02 71.75
Glaxosmi. Pharma 2,609.65 3,932.76 3,790.20 43.69 58.17
Cipla 1,466.00 20,102.60 18,979.95 38.53 13.88
Amrutanjan Healt 518.30 469.50 451.82 25.88 21.89
Fermenta Biotec. 465.55 474.15 450.25 21.32 18.77
Bliss GVS Pharma 454.10 773.53 729.81 49.74 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 33.64 19.52 3.94 23.52 6.77